Articles with public access mandates - Muthusamy KunnimalaiyaanLearn more
Not available anywhere: 1
Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma
S Koprowski, K Sokolowski, S Kunnimalaiyaan, TC Gamblin, ...
Journal of Surgical Research 198 (2), 434-440, 2015
Mandates: US National Institutes of Health
Available somewhere: 42
Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy
Y Xiao, R Jaskula-Sztul, A Javadi, W Xu, J Eide, A Dammalapati, ...
Nanoscale 4 (22), 7185-7193, 2012
Mandates: US National Institutes of Health
Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth
XM Yu, R Jaskula-Sztul, K Ahmed, AD Harrison, M Kunnimalaiyaan, ...
Molecular cancer therapeutics 12 (7), 1276-1287, 2013
Mandates: US National Institutes of Health
Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells
DY Greenblatt, MA Cayo, JT Adler, L Ning, MR Haymart, ...
Annals of surgery 247 (6), 1036-1040, 2008
Mandates: US National Institutes of Health
Hesperetin, a potential therapy for carcinoid cancer
B Zarebczan, SN Pinchot, M Kunnimalaiyaan, H Chen
The American journal of surgery 201 (3), 329-333, 2011
Mandates: US National Institutes of Health
Valproic acid induces Notch1 signaling in small cell lung cancer cells
CS Platta, DY Greenblatt, M Kunnimalaiyaan, H Chen
Journal of Surgical Research 148 (1), 31-37, 2008
Mandates: US National Institutes of Health
Identification and validation of Notch pathway activating compounds through a novel high‐throughput screening method
SN Pinchot, R Jaskula‐Sztul, L Ning, NR Peters, MR Cook, ...
Cancer 117 (7), 1386-1398, 2011
Mandates: US National Institutes of Health
Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer
M Truong, MR Cook, SN Pinchot, M Kunnimalaiyaan, H Chen
Annals of surgical oncology 18, 1506-1511, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells
JT Adler, DG Hottinger, M Kunnimalaiyaan, H Chen
Surgery 144 (6), 956-962, 2008
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Antiproliferative effect of chrysin on anaplastic thyroid cancer
TA Phan, XM Yu, M Kunnimalaiyaan, H Chen
Journal of Surgical Research 170 (1), 84-88, 2011
Mandates: US National Institutes of Health
Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride
JT Adler, DG Hottinger, M Kunnimalaiyaan, H Chen
Journal of Surgical Research 159 (2), 640-644, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Xanthohumol-mediated suppression of Notch1 signaling is associated with antitumor activity in human pancreatic cancer cells
S Kunnimalaiyaan, J Trevino, S Tsai, TC Gamblin, M Kunnimalaiyaan
Molecular cancer therapeutics 14 (6), 1395-1403, 2015
Mandates: US National Institutes of Health
Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3β
JT Adler, M Cook, Y Luo, SC Pitt, J Ju, W Li, B Shen, M Kunnimalaiyaan, ...
Molecular cancer therapeutics 8 (4), 914-920, 2009
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors
SC Pitt, H Chen, M Kunnimalaiyaan
Annals of surgical oncology 16, 2936-2942, 2009
Mandates: US National Institutes of Health
Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors
JT Adler, DG Hottinger, M Kunnimalaiyaan, H Chen
Annals of surgical oncology 16, 481-486, 2009
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
AKT and PTEN expression in human gastrointestinal carcinoid tumors
SC Pitt, R Davis, M Kunnimalaiyaan, H Chen
American journal of translational research 1 (3), 291, 2009
Mandates: US National Institutes of Health
Azacytidine induces cell cycle arrest and suppression of neuroendocrine markers in carcinoids
VM Alexander, M Roy, KA Steffens, M Kunnimalaiyaan, H Chen
International journal of clinical and experimental medicine 3 (2), 95, 2010
Mandates: US National Institutes of Health
Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression
S Kunnimalaiyaan, TC Gamblin, M Kunnimalaiyaan
HPB 17 (9), 770-776, 2015
Mandates: US National Institutes of Health
Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth
YM Carter, S Kunnimalaiyaan, H Chen, TC Gamblin, M Kunnimalaiyaan
Cancer biology & therapy 15 (5), 510-515, 2014
Mandates: US National Institutes of Health
Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma
A Dilip, G Cheng, J Joseph, S Kunnimalaiyaan, B Kalyanaraman, ...
Anti-cancer drugs 24 (9), 881-888, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program